Dec. 31 at 2:19 PM
$VCNX I’m a bit late to the party since I haven't checked the news lately, but to my surprise I saw that Friedberg injected another 60m$. Interestingly, he isn't focusing on the Oncology side and he's going all in on Neurology. If I were clueless about the latest CTAD 2025 data, knowing that Phase 2b success rates are generally low (especially in Neurology), I’d say Friedberg is a madman and I’d sell instantly (that is If I could even do so). In contrast, I am now convinced there is information far beyond what was shared in the CTAD presentation, specifically regarding the "Ast 10" findings I’ve been researching (Alzheimer's Association, Volume 21). To be clear, I believe this is a scientific breakthrough that will significantly shift the landscape in the future. While they're going standalone at this stage, knowing the science is on another level is reassuring enough for me. I truly hope this succeeds because the potential here is massive. Happy New Year Everyone!
